Topic
Efforts to extend lifespan or healthspan, including drug-target discovery and the implication that intervention timing may matter more than dosing.
Osaka researchers found CD4 cytotoxic T lymphocytes rise from 4 percent to 17.6 percent of circulating T cells across the oldest age brackets. Outside immunologists want function, not just counts.
Perspective Coverage
4 publishersReality
The $20mn round buys roughly 0.53 per cent of the company, and no product exists yet. Read the number as a reference price for pre-revenue bio-AI, not a verdict on the science.
Reality
An NIH-funded UC Berkeley team dosed old, healthy female mice, then fed a second group 24% fewer calories to match what the drug's appetite suppression achieved. The drug still did more on memory and blood sugar.
Reality
Researchers in Hong Kong and Georgia paired blood measurements with a Mendelian randomization arm. The male estimate survived where the female one stayed null. Neither arm looked at anyone taking the supplement.
Reality
Junyue Cao read 21 million cells from 14 organs and says aging arrives in discrete stages. If the staging holds, an intervention has a window rather than a dose.
Reality